Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03125356 · ClinicalTrials.gov registry record · NA
Low-calorie Sweeteners and Adipose Signaling
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03125356 is a NA study that has completed, run by George Washington University. The registered enrollment target is 10 participants.
The verdict
NCT03125356, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether eight weeks of low-calorie sweetener (LCS) exposure exerts cardiovascular and/or metabolic effects among LCS-naïve overweight and obese adolescents and young adults. We will examine changes in gene expression in subcutaneous fat and will correlate these molecular changes with plasma biochemistry.
Interventions
- OTHER Diet Soda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03125356
The ClinicalTrials.gov registry entry for NCT03125356 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diet Soda is the first listed.
NCT03125356 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03125356 about?
NCT03125356 is a clinical study titled "Low-calorie Sweeteners and Adipose Signaling". The purpose of this study is to determine whether eight weeks of low-calorie sweetener (LCS) exposure exerts cardiovascular and/or metabolic effects among LCS-naïve overweight and obese adolescents and young adults. We will examine changes in gene expression in subcutaneous fat and will correlate th...
What is the current status of trial NCT03125356?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-01-01. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03125356?
The interventions under investigation include: Diet Soda (OTHER).
Who is sponsoring clinical trial NCT03125356?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.